Showing results (1901-1910 of 4,531) with videos related to
Sort By:
Pageof 454
Neurourology and Urodynamics|March 8, 2016
Nerve growth factor does not seem to be a biomarker for neurogenic lower urinary tract dysfunction after spinal cord injuryJörg Krebs, David Pavlicek, Jivko Stoyanov, et al.Neurourology and Urodynamics|September 22, 2020
Long-term outcomes of transobturator midurethral slings: A critical evaluation of a real-world populationLibrado Valadez, Clifton F Frilot, Alex GomelskyNeurourology and Urodynamics|November 2, 2020
A large survey of nocturia related to sleep quality and daytime quality of life in a young Japanese population: NOCTURNE studyKazumasa Torimoto, Naohisa Uchimura, Eva Roitmann, et al.Neurourology and Urodynamics|July 23, 2022
Improvement of urethral dysfunction by 5-HT1A receptor agonist NLX-112 in diabetic ratsMingzhuo Li, Xun Chen, Nailong Cao, et al.Neurourology and Urodynamics|July 25, 2022
Exploring pelvic floor muscle function in men with and without pelvic floor symptoms: A population-based studyFrançoise J M Notenboom-Nas, Grietje E Knol-de Vries, Lotte Beijer, et al.Neurourology and Urodynamics|February 4, 2016
Toward a new generation of pelvic floor implants with electrospun nanofibrous matrices: A feasibility studyMahshid Vashaghian, Alejandra M Ruiz-Zapata, Manon H Kerkhof, et al.Neurourology and Urodynamics|January 13, 2016
Natural history of non-neurogenic overactive bladder and urinary incontinence over 5 years in community-dwelling older men: The concord health and aging in men projectNaomi Noguchi, Lewis Chan, Robert G Cumming, et al.Neurourology and Urodynamics|January 13, 2016
Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)Odile Troisgros, Jose-Luis Barnay, Farideh Darbon-Naghibzadeh, et al.Neurourology and Urodynamics|January 13, 2016
Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO): A randomised placebo-controlled phase IIa studyPierre Denys, Giulio Del Popolo, Gerard Amarenco, et al.Neurourology and Urodynamics|January 13, 2016
Reference values for frequency volume chart and uroflowmetry parameters in adolescent and adult enuresis patientsIlse Hofmeester, Astrid E Brinker, Martijn G Steffens, et al.Pageof 454